Sogroya

Indicated For

adult growth hormone deficiency, pediatric growth failure

About This Medication

# Growth Hormone Patient Assistance Program Patient Guide: How to Get Sogroya at Low or No Cost ## About This Program Novo Nordisk's Growth Hormone Patient Assistance Program, administered through **NovoCare®**, helps eligible patients access **Sogroya® (somapacitan-beco)** at no cost or reduced cost. Sogroya is a once-weekly growth hormone treatment for children and adults with growth hormone deficiency (GHD). This guide explains who qualifies, how to apply, and what to expect. ## About Sogroya (Somapacitan-beco) Sogroya is a prescription growth hormone medication that helps treat growth hormone deficiency in both children and adults. As the first once-weekly growth hormone injection, it offers a convenient treatment option for patients who need long-term growth hormone therapy. Sogroya has preferred coverage with major insurance companies including CVS Caremark®, Optum Rx®, Blue Cross Blue Shield®, TRICARE®, and others.[6] ## Who Qualifies for This Program? You may be eligible for the Growth Hormone Patient Assistance Program if you meet these criteria: **Basic Requirements:** - You are a U.S. citizen or legal resident[1] - You have a valid prescription for Sogroya from your healthcare provider - You demonstrate financial need based on your household income, location, and family size[2] - You have limited or no insurance coverage, or you are experiencing a gap or delay in coverage **Medical Eligibility:** You must have a diagnosis of growth hormone deficiency (GHD) or another FDA-approved growth hormone-related condition that Sogroya treats. ## Income Eligibility While specific 2026 income thresholds for Sogroya are not detailed in current program materials, Novo Nordisk's growth hormone programs typically use the following framework: | Household Size | Income Limit (% of Federal Poverty Level) | |---|---| | Individual | Up to 400% FPL (varies by program) | | Family of 2 | Up to 400% FPL (varies by program) | | Family of 3 | Up to 400% FPL (varies by program) | | Family of 4 | Up to 400% FPL (varies by program) | *Note: Income limits may vary. Contact NovoCare to confirm current thresholds for your household size.[1]* The program evaluates financial need based on: - Your total household yearly income - Where you live (cost of living varies by region) - The number of people living in your household - Your current insurance status[2] ## Insurance Requirements You may qualify for this program if you: - Have no prescription drug coverage - Have commercial insurance with coverage gaps or delays - Are experiencing a temporary lapse in coverage - Have Medicare Part D coverage but are in the "donut hole" (coverage gap)[9] **Important:** If you have active insurance coverage that includes Sogroya, you should explore your insurance benefits first. NovoCare can help verify your individual benefit coverage.[6] ## How to Apply: Step-by-Step ### Step 1: Gather Required Documents Before calling, have the following information ready: - **Proof of income** (recent tax return, pay stubs, or benefit statements) - **Proof of residency** (utility bill or lease agreement) - **Your prescription** for Sogroya (your doctor can provide this) - **Insurance information** (if applicable) - **Government ID** (may be requested) ### Step 2: Contact NovoCare Call **1-888-NOVO-444 (1-888-668-6444)** to begin your application. - **Hours:** 8:00 AM to 8:00 PM ET, Monday through Friday - You can apply by phone; no online form is required - A NovoCare representative will guide you through the process - Your healthcare provider will receive a secure email link to complete their portion of the application ### Step 3: Submit Documentation During your application call, you may be asked to provide: - Proof of income documentation - Proof of residency - Government ID - Insurance denial letter (if applicable) You can submit these documents by: - Fax: (888) 508-8200 - Email: through the secure link provided - Mail: to the address provided by NovoCare ### Step 4: Healthcare Provider Verification Your healthcare provider will receive a secure email with a link to: - Confirm your medical diagnosis - Verify your prescription for Sogroya - Provide any additional clinical information needed ### Step 5: Approval and Delivery If your application is approved: - You will receive a letter in the mail confirming your approval - You may also receive an automated phone or text message alert (if you opted in) - Neovance™ Specialty Pharmacy will call you at **1-800-488-5908** to schedule delivery - Your medication will be shipped directly to your home or your physician's office ## Timeline and What to Expect **Application Processing:** If you submit a complete application with all required documentation and fields filled out, your application will be processed within **2 business days**.[3] **Approval Timeline:** Most applications are reviewed within **2-4 weeks** from the date of submission. **Delivery:** Once approved, expect a call from Neovance Specialty Pharmacy within 5-7 business days to schedule delivery. **Program Duration:** If approved, you will receive free Sogroya for up to **one (1) year**, or until your financial or insurance status improves.[2] ## What If Your Application Is Delayed? Incomplete or missing information can delay your application. To avoid delays: - Provide all requested documentation at the time of application - Ensure all fields on the application are completed - Respond promptly to any requests for additional information from NovoCare ## What If Your Application Is Denied? If your application is denied, you have several options: 1. **Ask why you were denied** – Contact NovoCare to understand the specific reason 2. **Explore alternative programs** – NovoCare offers other assistance options, including: - **Sogroya Savings Card:** Up to $5,000 per year in co-pay assistance for patients with commercial insurance[5] - **Insurance reauthorization support:** NovoCare can help navigate insurance coverage issues 3. **Reapply if circumstances change** – If your income or insurance status changes, you may reapply 4. **Contact your healthcare provider** – Your doctor may have additional resources or alternative treatment options ## Reauthorization and Refills If you are approved for the program, you will need to **reauthorize annually** to continue receiving free medication. NovoCare will contact you before your current authorization expires to: - Verify your continued financial need - Update your income and household information - Confirm your ongoing medical need for Sogroya Your healthcare provider will also need to reauthorize your prescription with your insurance or the program. ## Important Reminders - **No registration fees or monthly charges** – The program is completely free to participate in[3] - **Product availability may change** – Novo Nordisk reserves the right to modify or cancel this program at any time without notice[3] - **Dedicated support** – Once enrolled, you will be assigned a dedicated NovoCare point of contact who can answer questions and keep things on track[5] - **Insurance verification available** – NovoCare can now verify your individual insurance benefit coverage before you apply[6] ## Disclaimer This guide provides general information about Novo Nordisk's Growth Hormone Patient Assistance Program as of March 2026. Program eligibility, income limits, required documentation, and benefits are subject to change without notice. For the most current and accurate information, contact NovoCare directly at **1-888-668-6444** or visit **NovoCare.com**. Always consult with your healthcare provider about your treatment options and eligibility for assistance programs. ## Contact Information **NovoCare® Patient Support:** - Phone: 1-888-NOVO-444 (1-888-668-6444) - Hours: 8:00 AM – 8:00 PM ET - Website: NovoCare.com **Neovance™ Specialty Pharmacy (Delivery):** - Phone: 1-800-488-5908

Program information last verified: March 30, 2026